New insider activity at Lifestance Health Group ( (LFST) ) has taken place on March 19, 2025.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Lisa K Miller, the Executive Vice President of Practice Operations at Lifestance Health Group, recently sold 18,845 shares of the company’s stock. This transaction amounted to a total value of $130,030.
Recent Updates on LFST stock
LifeStance Health Group, Inc. has recently reported strong financial results for the fourth quarter and full year of 2024, with a 19% increase in revenue to $1.251 billion and a 103% growth in Adjusted EBITDA to $119.7 million. Despite facing challenges such as flat rate expectations due to payer negotiations and increased general and administrative expenses, the company has demonstrated robust operational performance and strategic financial management. Key developments include a leadership transition with Dave Bourdon succeeding Ken Burdick as CEO, and the refinancing of existing debt under favorable terms. Looking forward, LifeStance projects continued growth in 2025, with revenue expectations between $1.40 billion and $1.44 billion, and plans to expand its centers to enhance access to mental healthcare services. These strategic initiatives and financial achievements have positioned LifeStance well for future growth, despite the challenges ahead.
More about Lifestance Health Group
YTD Price Performance: -8.74%
Average Trading Volume: 1,421,706
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.66B